Share Prices & Company Research

Stockbroking

Dechra Pharmaceuticals

Current Price 3870.00p Bid 3866.00p Ask 3870.00p Change 0.00%
Last Updated: 19/03/2024 07:26. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Financial Highlights Year Ended 30/06/2020

Revenue
£515.10m
Operating Profit/Loss
£52.20m
Dividend yield (%)
1.20
Total dividend for year
34.2900p
Dividend cover
2.70
P/E Ratio
30.80

Key Personnel

Mr Paul Sandland
CFO & Executive Director
Mr Ian Page
Chief Executive Officer
Mr Alison Platt
Non-Executive Director
Mr Geeta Gopalan
Non-Executive Director
Mr John Shipsey
Non-Executive Director
Mr Lawson Macartney
Non-Executive Director
Mr Lisa Bright
Non-Executive Director

Stock Details

EPIC
DPHL
ISIN
GB0009633180
Shares in Issue
88.09m
Market cap
£3,409.18m

Analyst Views (5)

Strong Buy
 
20.00%
Buy
 
40.00%
Hold
 
40.00%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
3,870.00p
Bid Price
3,866.00p
Ask Price
3,870.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
3,870.00p
Previous Close
3,870.00p
Intraday High
3,870.00p
Intraday Low
3,870.00p
52 Week High
3,870.00p
52 Week Low
2,554.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Income Statement

Year End Date
30 Jun 2020
30 Jun 2019
 
£ (M)
£ (M)
Continuing Operations
Revenue
515.10
481.80
Operating Profit/Loss
52.20
39.00
Net Interest
-11.00
-10.80
Pre-Tax Profit
40.90
27.80
Profit After Tax from continuing operations
33.90
30.90
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
33.90
30.90
Attributable to:
Equity Holders of Parent Company
33.90
30.90
Minority Interests
n/a
n/a
Total Dividend Paid
34.2900p
31.6000p
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
30 Jun 2020
30 Jun 2019
Basic
32.87p
30.15p
Diluted
32.76p
30.07p
Adjusted
92.50p
90.24p
Dividend per Share
34.2900p
31.6000p

Assets

Year End Date
30 Jun 2020
30 Jun 2019
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
76.40
58.40
Intangible Assets
692.20
680.60
Investment Properties
n/a
n/a
Investments
17.40
10.10
Other Financial Assets
n/a
n/a
Other Non-Current Assets
2.70
0.90
Current Assets
Inventories
120.80
103.50
Trade & Other Receivables
93.90
99.80
Cash at Bank & In Hand
227.40
80.30
Current Asset Investments
n/a
n/a
Other Current Assets
6.80
7.90
Other Assets
n/a
n/a
Total Assets
1,237.60
1,041.50

Liabilities

Year End Date
30 Jun 2020
30 Jun 2019
 
£ (M)
£ (M)
Current Liabilities
Borrowings
4.60
1.20
Other Current Liabilities
132.70
116.90
Total Current Liabilities
137.30
118.10
Non-Current Liabilities
Borrowings
350.40
306.90
Provisions
65.10
76.50
Other Non-Current Liabilities
47.30
30.90
Total Non-Current Liabilities
462.80
414.30
Other Liabilities
n/a
n/a
Total Liabilities
600.10
532.40

Net Assets

Year End Date
30 Jun 2020
30 Jun 2019
 
£ (M)
£ (M)
Net Assets
637.50
509.10

Capital & Reserves

Year End Date
30 Jun 2020
30 Jun 2019
 
£ (M)
£ (M)
Share Capital
1.10
1.00
Share Premium Account
409.30
277.90
Other Reserves
100.70
106.00
Retained Earnings
126.40
124.20
Shareholders Funds
637.50
509.10
Minority Interests/Other Equity
n/a
n/a
Total Equity
637.50
509.10

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Interim
09 Mar 2023
13 Apr 2023
12.50p
Final
27 Oct 2022
18 Nov 2022
32.89p
Interim
03 Mar 2022
07 Apr 2022
12.00p
Final
28 Oct 2021
19 Nov 2021
29.39p
Interim
04 Mar 2021
07 Apr 2021
11.11p
Final
05 Nov 2020
27 Nov 2020
24.00p
Interim
05 Mar 2020
08 Apr 2020
10.29p
Final
24 Oct 2019
15 Nov 2019
22.10p
Interim
07 Mar 2019
08 Apr 2019
9.50p
Final
25 Oct 2018
16 Nov 2018
18.17p
Interim
08 Mar 2018
06 Apr 2018
7.33p
Final
26 Oct 2017
17 Nov 2017
15.33p
Interim
09 Mar 2017
07 Apr 2017
6.11p
Final
27 Oct 2016
18 Nov 2016
12.91p
Interim
10 Mar 2016
06 Apr 2016
5.55p
Final
29 Oct 2015
20 Nov 2015
11.82p
Interim
12 Mar 2015
07 Apr 2015
5.12p

Dividend Metrics

Year End Date
30 Jun 2020
30 Jun 2019
Dividend growth
8.51%
23.92%
Dividend yield
1.20%
1.20%
Dividend cover
2.70
2.86


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.